COGT
Price
$27.35Alerts
Change
-$0.39 (-1.41%)
Updated
Nov 20, 11:41 AM (EDT)
Capitalization
5.49B
116 days until earnings call
Intraday BUY SELL Signals
SRRK
Price
$51.34Alerts
Change
+$0.96 (+1.91%)
Updated
Nov 20, 11:56 AM (EDT)
Capitalization
5.72B
109 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

COGT vs SRRK

COGT vs SRRK Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
COGT vs. SRRK commentary
Nov 20, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a Hold and SRRK is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for COGT with price predictions
Nov 19, 2026

COGT in downward trend: price dove below 50-day moving average on November 10, 2026

COGT moved below its 50-day moving average on November 10, 2026 date and that indicates a change from an upward trend to a downward trend. In 37 of 43 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on COGT as a result. In 80 of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 81%.

The Moving Average Convergence Divergence Histogram (MACD) for COGT turned negative on November 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 38 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 79%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where COGT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.

COGT broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where COGT's RSI Oscillator exited the oversold zone, 21 of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +13.39% 3-day Advance, the price is estimated to grow further. Considering data from situations where COGT advanced for three days, in 229 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

The Aroon Indicator entered an Uptrend today. In 147 of 192 cases where COGT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 77%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 26 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 32 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 71 (best 1 - 100 worst), indicating slightly worse than average price growth. COGT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.742) is normal, around the industry mean (3.596). P/E Ratio (-14.650) is within average values for comparable stocks, (-1.186). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.158). Dividend Yield (0.000) settles around the average of (131.631) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (443.347).

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for SRRK with price predictions
Nov 19, 2026

Momentum Indicator for SRRK turns positive, indicating new upward trend

SRRK saw its Momentum Indicator move above the 0 level on November 16, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 90 similar instances where the indicator turned positive. In 75 of the 90 cases, the stock moved higher in the following days. The odds of a move higher are at 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 53 of 64 cases where SRRK's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.

The Moving Average Convergence Divergence (MACD) for SRRK just turned positive on October 21, 2026. Looking at past instances where SRRK's MACD turned positive, the stock continued to rise in 41 of 50 cases over the following month. The odds of a continued upward trend are 82%.

SRRK moved above its 50-day moving average on November 18, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for SRRK crossed bullishly above the 50-day moving average on November 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 78%.

Following a +11.73% 3-day Advance, the price is estimated to grow further. Considering data from situations where SRRK advanced for three days, in 228 of 285 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

The Aroon Indicator entered an Uptrend today. In 91 of 123 cases where SRRK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 74%.

Bearish Trend Analysis

The 10-day RSI Indicator for SRRK moved out of overbought territory on November 10, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 similar instances where the indicator moved out of overbought territory. In 24 of the 25 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.

The 50-day moving average for SRRK moved below the 200-day moving average on November 03, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SRRK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.

SRRK broke above its upper Bollinger Band on November 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 36 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 38 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. SRRK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 50 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron Valuation Rating of 79 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (22.525) is normal, around the industry mean (3.596). P/E Ratio (-14.181) is within average values for comparable stocks, (-1.186). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.158). Dividend Yield (0.000) settles around the average of (131.631) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (443.347).

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
COGT vs SRRK: Fundamental Ratings
COGT
SRRK
OUTLOOK RATING
1..100
6042
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
79
Overvalued
PROFIT vs RISK RATING
1..100
3250
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
7144
P/E GROWTH RATING
1..100
2636
SEASONALITY SCORE
1..100
5038

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

COGT's Valuation (75) in the Miscellaneous industry is in the same range as SRRK (79) in the Biotechnology industry. This means that COGT’s stock grew similarly to SRRK’s over the last 12 months.

COGT's Profit vs Risk Rating (32) in the Miscellaneous industry is in the same range as SRRK (50) in the Biotechnology industry. This means that COGT’s stock grew similarly to SRRK’s over the last 12 months.

COGT's SMR Rating (99) in the Miscellaneous industry is in the same range as SRRK (99) in the Biotechnology industry. This means that COGT’s stock grew similarly to SRRK’s over the last 12 months.

SRRK's Price Growth Rating (44) in the Biotechnology industry is in the same range as COGT (71) in the Miscellaneous industry. This means that SRRK’s stock grew similarly to COGT’s over the last 12 months.

COGT's P/E Growth Rating (26) in the Miscellaneous industry is in the same range as SRRK (36) in the Biotechnology industry. This means that COGT’s stock grew similarly to SRRK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGTSRRK
RSI
ODDS (%)
Bullish Trend 5 days ago
81%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 12 days ago
84%
Bullish Trend 1 day ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 9 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
74%
COMPARISON
Comparison
Nov 20, 2026
Stock price -- (COGT: $27.74 vs. SRRK: $50.37)
Brand notoriety: COGT and SRRK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 66% vs. SRRK: 110%
Market capitalization -- COGT: $5.49B vs. SRRK: $5.72B
COGT [@Biotechnology] is valued at $5.49B. SRRK’s [@Biotechnology] market capitalization is $5.72B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $138.67B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 2 FA rating(s) are green while SRRK’s FA Score has 0 green FA rating(s).

  • COGT’s FA Score: 2 green, 3 red.
  • SRRK’s FA Score: 0 green, 5 red.
According to our system of comparison, SRRK is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 4 TA indicator(s) are bullish while SRRK’s TA Score has 7 bullish TA indicator(s).

  • COGT’s TA Score: 4 bullish, 5 bearish.
  • SRRK’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, SRRK is a better buy in the short-term than COGT.

Price Growth

COGT (@Biotechnology) experienced а -4.80% price change this week, while SRRK (@Biotechnology) price change was +16.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.27%. For the same industry, the average monthly price growth was -14.83%, and the average quarterly price growth was -25.31%.

Reported Earning Dates

COGT is expected to report earnings on Mar 16, 2027.

SRRK is expected to report earnings on Mar 09, 2027.

Industries' Descriptions

@Biotechnology (-9.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with TSHA. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then TSHA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
-0.25%
TSHA - COGT
48%
Loosely correlated
-5.51%
ROIV - COGT
48%
Loosely correlated
+0.59%
ORIC - COGT
47%
Loosely correlated
+0.65%
PVLA - COGT
47%
Loosely correlated
-0.55%
ENGN - COGT
47%
Loosely correlated
-4.86%
More

SRRK and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRRK has been loosely correlated with COGT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if SRRK jumps, then COGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRRK
1D Price
Change %
SRRK100%
+4.94%
COGT - SRRK
49%
Loosely correlated
-0.25%
RYTM - SRRK
46%
Loosely correlated
-1.88%
PTGX - SRRK
44%
Loosely correlated
-2.47%
VERA - SRRK
43%
Loosely correlated
+4.57%
CGON - SRRK
42%
Loosely correlated
+2.38%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PDDL12.492.27
+22.21%
GraniteShares 2x Long PDD Daily ETF (PDDL)
TAXM48.33N/A
N/A
Bondbloxx Ir+M Tax-Aware ETF For Massachusetts Residents
ISRA58.57-0.89
-1.50%
VanEck Israel ETF (ISRA)
DEM50.69-1.03
-1.99%
WisdomTree Emerging Markets High Dividend Fund (DEM)
IGD6.07-0.17
-2.72%
Voya Global Equity Dividend AND Premium Opportunity Fund